Filing Details

Accession Number:
0001171843-14-004911
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-22 21:02:23
Reporting Period:
2014-10-21
Filing Date:
2014-10-22
Accepted Time:
2014-10-22 20:02:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
3116 Akorn Inc AKRX Pharmaceutical Preparations (2834) 720717400
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365174 M Mark Silverberg 1925 West Field Court Suite 300
Lake Forest IL 60045
Exec Vp, Ops Global Qa&Techsrv No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-21 50,000 $1.11 119,911 No 4 M Direct
Common Stock Acquisiton 2014-10-21 50,000 $1.60 169,911 No 4 M Direct
Common Stock Acquisiton 2014-10-21 35,000 $1.60 204,911 No 4 M Direct
Common Stock Acquisiton 2014-10-21 75,000 $1.60 279,911 No 4 M Direct
Common Stock Disposition 2014-10-21 72,491 $40.00 207,420 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2014-10-21 50,000 $0.00 50,000 $1.11
Common Stock Stock Options (Right to Buy) Disposition 2014-10-21 50,000 $0.00 50,000 $1.60
Common Stock Stock Options (Right to Buy) Disposition 2014-10-21 35,000 $0.00 35,000 $1.60
Common Stock Stock Options (Right to Buy) Disposition 2014-10-21 75,000 $0.00 75,000 $1.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-05-26 No 4 M Direct
0 2014-11-19 No 4 M Direct
0 2014-11-19 No 4 M Direct
0 2014-11-19 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2014.
  2. Proceeds from the sale were used to pay exercise price and taxes due upon exercise of options.
  3. Amount of Shares Beneficially Owned Following Reported Transaction includes 22,535 unvested shares subject to a restricted stock awards and 184,885 shares owned outright.
  4. The option vested in three annual installments with 16,666 options vesting on May 26, 2010, and 16,667 options vesting on each of May 26, 2011 and May 26, 2012.
  5. The option vested in three annual installments with 16,666 options vesting on November 19, 2010, and 16,667 options vesting on each of November 19, 2011 and November 19, 2012.
  6. The option vested in four annual installments with 8,750 vesting on each of November 19, 2009, November 19, 2010, November 19, 2011, and November 19, 2012.
  7. The option vested in four annual installments with 18,750 vesting on each of November 19, 2009, November 19, 2010, November 19, 2011, and November 19, 2012
  8. There was no consideration given in exchange for the security.